Polidocanol injection therapy for small-bowel hemangioma by using double-balloon endoscopy

Igawa, Atsushi; Oka, Shiro; Tanaka, Shinji; Kunihara, Sayoko; Nakano, Makoto; Chayama, Kazuaki

doi:10.1016/j.gie.2016.02.021

Cited by 29 publications

(25 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The color change of the lesion and degree of swelling at the time of injection should also be monitored. The optimal amount of polidocanol for injection has been reported to be 0.2 mL per mm of tumor size (7). In addition to hemangiomas, the intralesional administration of 1% polidocanol has been reported to be safe and effective for the management of vascular malformations, including arteriovenous malformation (21).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma

et al. 2020

View full text Add to dashboard Cite

Small-bowel hemangiomas are a possible source of gastrointestinal bleeding for which there is no established treatment approach. In this report, we describe the case of a 58-year-old woman who presented with hematochezia and who was diagnosed with small bowel hemangioma. She was successfully treated using endoscopic sclerotherapy. Initial capsule endoscopy revealed bleeding in the ileum. Subsequent double-balloon enteroscopy showed a 2-cm, bluish-purple, ileal submucosal tumor with an overlying protrusion. The lesion was responsible for the hematochezia and was treated with intralesional injection of polidocanol. The hematochezia completely resolved and at 4 months after sclerotherapy, the size of the lesion was significantly reduced.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Moreover, it can also be used to manage esophageal hemangiomas ( 6 ). Nevertheless, few reports have described the use of endoscopic sclerotherapy for the treatment of small bowel hemangiomas ( 7 - 9 ). Additional reports on the clinical usefulness of this procedure are needed to ascertain its utility.…”

Section: Introductionmentioning

confidence: 99%

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Therapeutic interventions for PHE have been reported in 5–38.9% of patients with PHE, including endoscopic treatment using balloon endoscopy, radiological interventions and surgery, argon plasma coagulation and/or hemoclips, and polidocanol injection having been used to achieve hemostasis [22, 25, 31, 33-35]. Various modalities have also been used for the treatment of small-bowel varices [36-40].…”

Section: Discussionmentioning

confidence: 99%

Predictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients with Liver Cirrhosis: A Capsule Endoscopy Study

et al. 2018

Self Cite

View full text Add to dashboard Cite

Background/Aims: The clinical course and exacerbation of portal hypertensive enteropathy (PHE) are yet to be fully clarified. This study aimed to identify factors related to PHE exacerbation in patients with liver cirrhosis (LC). Methods: Fifty patients with LC (33 male; mean age, 67 years), who underwent capsule endoscopy (CE) at the Hiroshima University Hospital between February 2009 and September 2015, were followed up for >6 months. Exacerbation is defined as the appearance of new lesions or worsening of existing lesions. The association between PHE exacerbation and the clinical factors was evaluated. Results: PHE exacerbation was identified in 24 out of 50 (48%) of cases: erythema (14 cases); angioectasia (11 cases); erosions (9 cases); villous edema (8 cases); and esophageal varices (EVs; 6 cases). The following factors were significantly associated with PHE exacerbation: portosystemic shunts, EVs and portal hypertensive gastropathy (PHG) exacerbation. After therapy, CE findings among the 24 cases were as follows: villous edema (19 cases); erythema (17 cases); angioectasia (16 cases); erosions (12 cases); and EVs (9 cases), and no observable abnormalities in 2 cases. On multivariate analysis, exacerbation of EVs and PHG were independent predictors of PHE exacerbation. Conclusion: EVs and PHG exacerbation may predict PHE exacerbation in patients with LC.

show abstract

“…DAE has also been used to perform therapeutic procedures, similarly to conventional endoscopy and colonoscopy, for instance hemostasis, polypectomy, endoscopic mucosal resection, and stent placement ( 32 - 34 ).…”

Section: Role Of Therapeutic Enteroscopymentioning

confidence: 99%

“…They may cause abdominal pain, bleeding and/or obstruction. Advances in endoscopic techniques with argon plasma coagulation, and sclerotherapy, have led to successful endoscopic interventions, however large lesions need surgical resection ( 33 , 34 , 48 ) ( Figure 2A , B ).…”

Section: Benign Tumorsmentioning

confidence: 99%

Impact of enteroscopy on diagnosis and management of small bowel tumors

Safatle‐Ribeiro

Ribeiro

2020

Chinese Journal of Cancer Research

View full text Add to dashboard Cite

Small bowel tumors (SBTs) have been increasingly diagnosed in recent decades. The pathogenesis of this increment is largely unknown, but advances in radiological and endoscopic methods facilitate the improvement of the diagnosis. Capsule endoscopy (CE) and device-assisted enteroscopy (DAE) allow the clinician to assess the entire small bowel in the search for suspicious lesions, or a cause of symptoms. In this review, we discuss the role of enteroscopy, techniques and strategies in the diagnosis and management of SBTs, and a brief description of the most common tumors.

show abstract

Polidocanol injection therapy for small-bowel hemangioma by using double-balloon endoscopy

Abstract: PDI is an easy, safe, and effective method to treat small-bowel hemangiomas.

Cited by 29 publications

References 30 publications

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma

Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma

Predictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients with Liver Cirrhosis: A Capsule Endoscopy Study

Impact of enteroscopy on diagnosis and management of small bowel tumors

Contact Info

Product

Resources

About